GT BIOPHARMA INC - COM NEW (GTBP)

CUSIP: 36254L209

Q4 2021 13F Holders as of 31 Dec 2021

Share change
+685,209
Put/Call ratio
149%
SEC-reported price per share
$3.05
Number of holders
51
Value change
+$1,155,626
Number of buys
31
Open additional details 1 more signal available
Number of sells
16

Security key

36254L209

Report period

Q4 2021

Institutions

51

Top holders

10

Ownership snapshot

Top reported holders of GTBP - GT BIOPHARMA INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $7,786,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $7.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $7.79M
VANGUARD GROUP INC $6.49M
STATE STREET CORP $3.16M
GEODE CAPITAL MANAGEMENT, LLC $2.86M
MORGAN STANLEY $1.7M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$7,786,000
1,155,228 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$6,493,000
963,323 shares
— 30 Sep 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$3,161,000
469,028 shares
— 30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$2,859,000
424,279 shares
— 30 Sep 2021
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$1,701,000
252,266 shares
— 30 Sep 2021
NORTHERN TRUST CORP
13F
Company
13F
—
denominator unverified
$1,127,000
167,095 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
51
Shares
5,475,887
Rows available
51
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
52
Q4 2021 holders
51
Holder diff
-1
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .